Clinical Trials Directory

Trials / Unknown

UnknownNCT02899624

Whole Exome Sequencing in Bicuspid Aortic Valve Patients

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
427 (estimated)
Sponsor
Assistance Publique Hopitaux De Marseille · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Bicuspid aortic valve (BAV), congenital anomaly present in 2% of the population, is defined by the presence of two sigmoid valves instead of three. It is conventionally associated with histological abnormalities of the wall of the ascending aorta, risk factors of aortic dystrophy observed in 50% of cases, and dissection. Long considered an accident of development, the discovery of mutations in the NOTCH1 gene in 2 families alternating BAV and aortic dystrophy suggests the existence of a genetic predisposition and a common genetic origin for these two pathologies. Data on the genetic basis of the BAV are still limited, but the existence of a large phenotypic diversity suggests the involvement of other genes. The establishment of large collections of DNA will allow great advances in this field. The purpose of this project is to confirm the existence of a genetic determinism at the origin of the BAV with or without dystrophy of non syndromic ascending aorta, identifying genetic defects associated with the presence of a BAV in a series of candidate genes.

Conditions

Interventions

TypeNameDescription
BIOLOGICALExtra blood draw samples
BIOLOGICALadditional tissue samples

Timeline

Start date
2014-01-01
Primary completion
2017-01-01
Completion
2018-01-01
First posted
2016-09-14
Last updated
2016-09-14

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02899624. Inclusion in this directory is not an endorsement.